Author: Jason Curtis

The novel use of dental suction tubing in the decompression of large dental cysts (2017)

Posted on by

Type of publication:
Conference abstract

Author(s):
*Otukoya R.; *Mihalache G.; *Castling B.

Citation:
British Journal of Oral and Maxillofacial Surgery; Dec 2017; vol. 55 (no. 10)

Abstract:
Introduction: Dental suction tubing is widely available in OMFS Units. It has a metal radiopaque marker and can easily be cut to the desired length with scissors. It is relatively inexpensive and has a reinforced lumen that makes easy access for saline irrigation.We have used this tubing now in 3 large odontogenic cysts of the jaws and present this as an aid to effective and simple cyst decompression. Materials/Methods: Large odontogenic cysts present a surgical challenge in terms of recurrence prevention, protection of the inferior dental nerve and teeth and avoidance of mandibular fracture. We have effectively managed 3 such cases with the insertion of a segment of dental suction tubing as a decompression grommet at the same time as local anaesthetic biopsy of the cyst lining. The tube rigidity maintains patency and it is robust enough to allow easy self-irrigation by the patient. The position of the tubing can be assessed radiographically. Results: We allowed decompression over a 3 to 6 month period prior to formal cyst enucleation. There were no complications or failures of the tube patency. The benefits of decompression were clear as a demonstrable bony infilling and reduction in cyst size. Additionally the cyst lining became markedly thicker and easier to enucleate intact, an advantage in odontogenic kearatocysts. Conclusions:We would like to commend this dental suction tube grommet technique as an effective way to manage large odontogenic cysts of the jaws.

Sex differences in the splenic flexure (2017)

Posted on by

Type of publication:
Journal article

Author(s):
Brookes A.F.; Macano C.; Meecham L.; *Stone T.; *Cheetham M.

Citation:
Annals of the Royal College of Surgeons of England; Jul 2017; vol. 99 (no. 6); p. 456-458

Abstract:
INTRODUCTION Anecdotally, surgeons claim splenic flexure mobilisation is more difficult in male patients. There have been no scientific studies to confirm or disprove this hypothesis. The implications in colorectal surgery could be profound. The aim of this study was to assess quantitatively whether there is an anatomical difference in the position of the splenic flexure between men and women using computed tomography (CT). METHODS Portal venous phase CT performed for preoperative assessment of colorectal malignancy was analysed using the hospital picture archiving and communication system. The splenic flexure was compared between men and women using two variables: anatomical height corresponding to the adjacent vertebral level (converted to ordinal values between 1 and 17) and distance from the midline. RESULTS In total, 100 CT images were analysed. Sex distribution was even. The mean ages of the male and female patients were 68.1 years and 66.7 years respectively (p=0.630). The mean vertebral level for men was 8.88, equating to the inferior half of the T11 vertebral body (range: 1-17 [superior half of T9 to inferior half of L2]), and 11.36 for women, equating to the inferior half of the T12 vertebral body (range: 4-16 [superior half of T10 to superior half of L2]). This difference was statistically significant (p=0.0001) and is equivalent to one whole vertebra. The mean distance from the midline was 160.8mm (range: 124-203mm) for men and 138.2mm (range: 107-185mm) for women (p<0.0001). CONCLUSIONS The splenic flexure is both higher and further from the midline in men than in women. This provides one theory as to why mobilising the splenic flexure may be more difficult in male patients.

Link to full-text [Available to eligible users with an NHS OpenAthens account]

Managing glycaemic trends in people with diabetes requiring enteral feeding support: The challenges in primary and secondary care (2017)

Posted on by

Type of publication:
Journal article

Author(s):
*Richardson, Erica A.; Agbasi, Nneka

Citation:
Journal of Diabetes Nursing; Aug 2017; vol. 21 (no. 7); p. 241-246

Abstract:
Matching therapeutic treatments to manage glycaemic excursions in people with diabetes receiving enteral nutrition (e.g. nasogastric, gastrostomy or jejunostomy) can be difficult. There is evidence to suggest that there is an increased risk of complications and mortality, longer lengths of stay in hospital, higher risk of intensive care input and higher demands for transitional or nursing home care post discharge. Other intrinsic factors, such as illness, timing of medications, poly-pharmacy, types of feeding regimen chosen and history of diabetes, all need to be considered when choosing appropriate treatments. This article describes the challenges of supporting people with diabetes requiring enteral feeding and the implications for diabetes nurses.

Link to full-text [no password required]

Auditing the complications of LLETZ cervical treatment versus cold-coagulation over a one-year period (2017)

Posted on by

Type of publication:
Conference abstract

Author(s):
*Ali N.; *Kandareachichi P.; *Blackmore J.; *Papoutsis D.; *Panikkar J.

Citation:
BJOG: An International Journal of Obstetrics and Gynaecology; Nov 2017; vol. 124 ; p. 33

Abstract:
Introduction We aim to audit the complication rates of women treated with either LLETZ cervical treatment or cold-coagulation in our colposcopy unit against the standards set out by the NHSCSP guidelines. It is reported that the proportion of treatment associated with primary haemorrhage that requires a haemostatic technique must be less than 5%, and the proportion of cases admitted as inpatients because of treatment complications must be less than 2%. Methods We retrospectively collected data from our electronic colposcopy database for women treated over the time period of August 2015 – July 2016. Hospital notes were retrieved for those who were identified with complications for further data collection. Results We identified 494 patients with LLETZ and 24 patients with cold-coagulation treatment. There were no complications noted after cold-coagulation. There were 12/494 (2.4%) patients who had post-LLETZ bleeding with one patient being admitted as an inpatient for further management (1/518 or 0.2). The bleeding occurred between 2-28 days after treatment, with 42% of women having had treatment under a general anaesthetic mainly due to a large lesion size. The mean age of women with bleeding was 39 years (range: 27-59) with a mean BMI of 26 kg/m2 (range: 17-34). Only one in three women with bleeding required oral antibiotics, and less than 8% of women had a temporary vaginal pack. All women with bleeding were self-referred directly to the colposcopy service without prior GP consultation/examination. Conclusion We are compliant with the NHS-CSP auditable standards with regards to post-treatment complications and inpatient admissions. As very few women actually necessitated further management this puts into question the appropriateness of the initial referral of these women. Areas for improvement therefore involve educating both staff and patients about the possibility of bleeding after excisional treatment and the role of the GP in reviewing these women before onward referral to the colposcopy service.

Does gestational weight gain of more than 12 kg in women increase the risk of a cesarean section delivery, gestational diabetes and pregnancy induced hypertension? A retrospective case series (2017)

Posted on by

Type of publication:
Journal article

Author(s):
Antonakou A.; *Papoutsis D.; Kechagia A.

Citation:
Clinical and Experimental Obstetrics and Gynecology; 2017; vol. 44 (no. 4); p. 540-544

Abstract:
Purpose: The purpose of this study was to investigate whether the gestational weight gain of more than 12 kg represented a risk factor for an increased rate of cesarean section (CS) delivery, gestational diabetes, and pregnancy-induced hypertension (PIH). Materials and Methods: This was a retrospective case series study performed in a Greek National Health Service hospital and included women having given birth to singleton pregnancies between 2004-2009. Cases with multiple pregnancies, stillbirths, and congenital fetal abnormalities were excluded. Results: 600 eligible women were included in the study. Gestational weight increase correlated positively and was higher in women with a CS delivery, gestational diabetes, and PIH. The prepregnancy body mass index was identified as a predictor of gestational diabetes. The weight gain of less than 12 kg during pregnancy provided a protective effect against CS delivery by reducing the likelihood of this by 85%. Conclusion: The present authors have shown that the increased body weight gain during pregnancy of more than 12 kg is associated with increased rates of CS delivery, gestational diabetes, and hypertensive disorders in pregnancy.

Motor neuron disease in otolaryngology - A review (2017)

Posted on by

Type of publication:
Journal article

Author(s):
*Fussey J.M.; *Skinner D.W.

Citation:
Otorhinolaryngologist; 2017; vol. 10 (no. 2); p. 79-81

Abstract:
Motor neuron disease is an incurable neurodegenerative disorder affecting both upper and lower motor neurons, resulting in progressive weakness and inevitable death due to respiratory failure. Up to 30% of patients present with bulbar symptoms and therefore may be seen first by an otolaryngologist. Furthermore, almost all patients experience bulbar symptoms in the late stages of the disease and may require the input of an otolaryngologist as part of their multidisciplinary management.

Effect of latanoprost on thyroid orbitopathy (2017)

Posted on by

Type of publication:
Journal article

Author(s):
*Ha J.; *Zunz E.; *Sagili S.

Citation:
Expert Review of Ophthalmology; Nov 2017; vol. 12 (no. 6); p. 437-441

Abstract:
Background: Prostaglandin F2alpha analogues are known to reduce human orbital fibroblasts proliferation and adipogenesis and may be used as a potential therapy for treatment of thyroid orbitopathy. The aim of this study was to identify any beneficial effect of latanoprost on thyroid orbitopathy, in the form of reduction in proptosis, secondary to prostaglandin associated periorbitopathy. Methods: A retrospective case review of 11 patients (22 eyes) with thyroid eye disease who were using latanoprost for management of ocular hypertension. Patients receiving systemic immunosuppressants were excluded. Orbital imaging was analysed where available. A change in proptosis was analysed based on Hertel exophthalmometry. Results: Three patients (27%) had >= 2 mm reduction in proptosis and they all had fat predominant thyroid orbitopathy, as evident on orbital imaging. Proptosis remained unchanged or improved by less than 2mm in the rest of the patients (73%). Overall, mean pre treatment exophthalmometry was 22.4 mm (range 15-30 mm) and mean post treatment exophthalmometry was 20.6 mm (range 15-29 mm). Conclusion: Latanoprost was well tolerated in patients with thyroid orbitopathy. Objective reduction in proptosis of 2mm or more was noted in 3 patients (27%) and none of the patients had an increase in proptosis. The improvement in proptosis may be more pronounced in patients with fat predominant orbits.

Group pre-assessment for patients undergoing chemotherapy: Our experience at The Royal Shrewsbury Hospital (2017)

Posted on by

Type of publication:
Conference abstract

Author(s):
*Allos B.; *Redgrave R.; *Davies W.; *Chatterjee A.

Citation:
Lung Cancer; Jan 2017; vol. 103, Supplement 1, Page S47

Abstract:
Introduction: Waiting time targets in England and Wales state cancer treatment must commence within 31 days of the treatment plan being agreed. Often, pressures on chemotherapy units, such as low staffing levels and capacity, delays starting chemotherapy. This may impact outcomes. To improve capacity and waiting times we have implemented group pre-assessment (GPAC) for all prospective chemotherapy patients at our trust. Methods: Previously each patient received a 1-hour pre-assessment appointment with a dedicated nurse. For non-urgent patients we have established GPAC clinics since January 2014. These are run three times a week by volunteers in conjunction with one chemotherapy nurse and accommodate 6 patients per session. Patients watch a 25-minute DVD providing general information on chemotherapy in addition to introducing the unit, nurses and general treatment procedures. A unit tour follows this. Each patient receives a diagnosis-specific  tumour pack and the session concludes with a 10-minute one-to-one meeting with a nurse to discuss their personal treatment regime. Results: We pre-assess up to 18 patients a week via GPAC. Since implementation we have reduced nursing hours needed for this service to a maximum of 6 hours per week. From September 2015 to August 2016 a total of 667 patients attended GPAC clinic with 312 nursing hours required. Our unit has consequently saved 355 nursing hours over that time period (Figure 1). Patient satisfaction with the service remains high with 24/25 (96%) of patients surveyed rating the service as good to excellent across five categories. With GPAC initiation, our average chemotherapy waiting time has reduced to 13 days from over 20 days. Conclusion: By initiating GPAC our department has significantly saved nursing hours allowing us to reallocate these to chemotherapy delivery and service development. With increased capacity to treat patients waiting times have been significantly reduced. This has not been to the detriment of patient satisfaction. (Table Presented).